HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) A correction has been published Alert me when this article is cited Alert me if a correction is posted Citation Map Services Related articles in The JI Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lum, J. J. Articles by Badley, A. D. Search for Related Content PubMed PubMed Citation Articles by Lum, J. J. Articles by Badley, A. D.

Elimination of Senescent Neutrophils by TNF-Related Apoptosis-Inducing Ligand¹

Julian J. Lum^*, Gary Bren^*, Rebecca McClure and Andrew D. Badley^2,,

^* Division of Infectious Diseases, Department of Laboratory Medicine and Pathology, Program in Translational Immunovirology and Biodefense, Mayo Clinic College of Medicine, Rochester, MN 55905

Neutrophils are phagocytic effectors which are produced in the bone marrow and released into the circulation. Thereafter, they are either recruited to sites of inflammation or rapidly become senescent, return to the bone marrow, and undergo apoptosis. Stromal cell-derived factor 1 (SDF-1) coordinates the return of senescent neutrophils to the bone marrow by interacting with CXCR4 that is preferentially expressed on senescent neutrophils. We demonstrate that CXCR4 ligation by SDF-1 or other CXCR4 agonists significantly increases the expression of both TNF-related apoptosis-inducing ligand (TRAIL) and of the death-inducing TRAIL receptors on neutrophils, which confers an acquired sensitivity to TRAIL-mediated death and results in TRAIL-dependent apoptosis. In vivo administration of TRAIL antagonists results in neutrophilic accumulation within the bone marrow and a reduction in neutrophil apoptosis; conversely recombinant TRAIL administration reduced neutrophil number within bone marrow. Thus, SDF-1 ligation of CXCR4 causes the parallel processes of chemotaxis and enhanced TRAIL and TRAIL death receptor expression, resulting in apoptosis of senescent neutrophils upon their return to the bone marrow.

Related articles in The JI:

Leptin promotes differentiation and survival of human dendritic cells and licenses them for Th1 priming

B. Mattioli, E. Straface, M. G. Quaranta, L. Giordani, and M. Viora
The JI 2005 175: 3446. [Full Text]  

This article has been cited by other articles:

				G. Zaza, P. Pontrelli, G. Pertosa, S. Granata, M. Rossini, S. Porreca, F. J. T. Staal, L. Gesualdo, G. Grandaliano, and F. P. Schena Dialysis-related systemic microinflammation is associated with specific genomic patterns Nephrol. Dial. Transplant., May 1, 2008; 23(5): 1673 - 1681. [Abstract] [Full Text] [PDF]

				M. P. Simons, K. G. Leidal, W. M. Nauseef, and T. S. Griffith TNF-related apoptosis-inducing ligand (TRAIL) is expressed throughout myeloid development, resulting in a broad distribution among neutrophil granules J. Leukoc. Biol., March 1, 2008; 83(3): 621 - 629. [Abstract] [Full Text] [PDF]

				I. Neeli, S. N. Khan, and M. Radic Histone Deimination As a Response to Inflammatory Stimuli in Neutrophils J. Immunol., February 1, 2008; 180(3): 1895 - 1902. [Abstract] [Full Text] [PDF]

				G. Castellino, F. Corallini, F. Trotta, and P. Secchiero Elevated levels of TRAIL in systemic lupus erythematosus are associated to the presence of anti-SSA/SSB antibodies Lupus, July 1, 2007; 16(7): 479 - 482. [Abstract] [PDF]

				M. A. Cassatella On the production of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2L) by human neutrophils J. Leukoc. Biol., June 1, 2006; 79(6): 1140 - 1149. [Abstract] [Full Text] [PDF]